Does DUVELISIB Cause Off label use? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Off label use have been filed in association with DUVELISIB (COPIKTRA). This represents 7.5% of all adverse event reports for DUVELISIB.
57
Reports of Off label use with DUVELISIB
7.5%
of all DUVELISIB reports
4
Deaths
8
Hospitalizations
How Dangerous Is Off label use From DUVELISIB?
Of the 57 reports, 4 (7.0%) resulted in death, 8 (14.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUVELISIB. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does DUVELISIB Cause?
Product use in unapproved indication (162)
Diarrhoea (110)
Death (89)
Fatigue (75)
Prescribed underdose (63)
Nausea (49)
Pneumonia (40)
Pyrexia (40)
Malignant neoplasm progression (38)
Rash (33)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DUVELISIB Alternatives Have Lower Off label use Risk?
DUVELISIB vs DYDROGESTERONE
DUVELISIB vs EBASTINE
DUVELISIB vs ECALLANTIDE
DUVELISIB vs ECONAZOLE
DUVELISIB vs ECULIZUMAB